[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C165H194N12O16 — CID 157268121

IUPAC[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
SMILESCC(C)C(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21
InChIInChI=1S/C47H55N3O4.C46H55N3O4.C43H53N3O4.C29H31N3O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23-32-45(51)53-39-50-44-31-25-30-43(46(44)54-47(50)52)49-35-33-48(34-36-49)38-40-26-24-29-42(37-40)41-27-21-20-22-28-41;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-31-44(50)52-38-49-43-30-24-29-42(45(43)53-46(49)51)48-34-32-47(33-35-48)37-39-25-23-28-41(36-39)40-26-20-19-21-27-40;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-28-41(47)49-35-46-40-27-21-26-39(42(40)50-43(46)48)45-31-29-44(30-32-45)34-36-22-20-25-38(33-36)37-23-17-16-18-24-37;1-21(2)28(33)35-20-32-26-13-7-12-25(27(26)36-29(32)34)31-16-14-30(15-17-31)19-22-8-6-11-24(18-22)23-9-4-3-5-10-23/h3-4,6-7,9-10,12-13,15-16,18-22,24-31,37H,2,5,8,11,14,17,23,32-36,38-39H2,1H3;4-5,7-8,10-11,13-14,16-17,19-21,23-30,36H,2-3,6,9,12,15,18,22,31-35,37-38H2,1H3;3-4,6-7,9-10,16-18,20-27,33H,2,5,8,11-15,19,28-32,34-35H2,1H3;3-13,18,21H,14-17,19-20H2,1-2H3/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-;5-4-,8-7-,11-10-,14-13-,17-16-;4-3-,7-6-,10-9-;
InChIKeyAYFNLOYTFYDZPC-DXZSKNFXSA-N
MW2601.43 g/mol
LogP35.37
Rot. Bonds66

About [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate (PubChem CID 157268121) has the molecular formula C165H194N12O16 and a molecular weight of 2601.43 g/mol. Its IUPAC name is [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate.

Molecular Properties

Compound Name[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
PubChem CID157268121
Molecular FormulaC165H194N12O16
Molecular Weight2601.43 g/mol
Exact Mass2599.47
IUPAC Name[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
SMILESCC(C)C(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21
InChIInChI=1S/C47H55N3O4.C46H55N3O4.C43H53N3O4.C29H31N3O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23-32-45(51)53-39-50-44-31-25-30-43(46(44)54-47(50)52)49-35-33-48(34-36-49)38-40-26-24-29-42(37-40)41-27-21-20-22-28-41;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-31-44(50)52-38-49-43-30-24-29-42(45(43)53-46(49)51)48-34-32-47(33-35-48)37-39-25-23-28-41(36-39)40-26-20-19-21-27-40;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-28-41(47)49-35-46-40-27-21-26-39(42(40)50-43(46)48)45-31-29-44(30-32-45)34-36-22-20-25-38(33-36)37-23-17-16-18-24-37;1-21(2)28(33)35-20-32-26-13-7-12-25(27(26)36-29(32)34)31-16-14-30(15-17-31)19-22-8-6-11-24(18-22)23-9-4-3-5-10-23/h3-4,6-7,9-10,12-13,15-16,18-22,24-31,37H,2,5,8,11,14,17,23,32-36,38-39H2,1H3;4-5,7-8,10-11,13-14,16-17,19-21,23-30,36H,2-3,6,9,12,15,18,22,31-35,37-38H2,1H3;3-4,6-7,9-10,16-18,20-27,33H,2,5,8,11-15,19,28-32,34-35H2,1H3;3-13,18,21H,14-17,19-20H2,1-2H3/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-;5-4-,8-7-,11-10-,14-13-,17-16-;4-3-,7-6-,10-9-;
InChIKeyAYFNLOYTFYDZPC-DXZSKNFXSA-N
XLogP35.37
TPSA271.68 Ų
H-Bond Donors
H-Bond Acceptors28
Rotatable Bonds66
Heavy Atoms193
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002601.43
LogP ≤ 535.37
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl hexanoate
CID 49854182
[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl hexadecanoate
CID 49854183
[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl octanoate
CID 49854390
[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl decanoate
CID 49854598
[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl dodecanoate
CID 49854599
[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl tetradecanoate
CID 49854600
[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylbutanoate
CID 49854601
[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl cyclopentanecarboxylate
CID 49854816
[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl cyclohexanecarboxylate
CID 49854817
[2-Oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl pentanoate
CID 58096614
[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
CID 58096685
[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate
CID 58096724

Frequently Asked Questions

What is the IUPAC name of [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate?
The IUPAC name of [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate (CID 157268121) is [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate.
What is the SMILES notation for [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate?
The canonical SMILES for [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate is CC(C)C(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21.
What is the InChIKey of [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate?
The InChIKey is AYFNLOYTFYDZPC-DXZSKNFXSA-N. The full InChI is InChI=1S/C47H55N3O4.C46H55N3O4.C43H53N3O4.C29H31N3O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23-32-45(51)53-39-50-44-31-25-30-43(46(44)54-47(50)52)49-35-33-48(34-36-49)38-40-26-24-29-42(37-40)41-27-21-20-22-28-41;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-31-44(50)52-38-49-43-30-24-29-42(45(43)53-46(49)51)48-34-32-47(33-35-48)37-39-25-23-28-41(36-39)40-26-20-19-21-27-40;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-28-41(47)49-35-46-40-27-21-26-39(42(40)50-43(46)48)45-31-29-44(30-32-45)34-36-22-20-25-38(33-36)37-23-17-16-18-24-37;1-21(2)28(33)35-20-32-26-13-7-12-25(27(26)36-29(32)34)31-16-14-30(15-17-31)19-22-8-6-11-24(18-22)23-9-4-3-5-10-23/h3-4,6-7,9-10,12-13,15-16,18-22,24-31,37H,2,5,8,11,14,17,23,32-36,38-39H2,1H3;4-5,7-8,10-11,13-14,16-17,19-21,23-30,36H,2-3,6,9,12,15,18,22,31-35,37-38H2,1H3;3-4,6-7,9-10,16-18,20-27,33H,2,5,8,11-15,19,28-32,34-35H2,1H3;3-13,18,21H,14-17,19-20H2,1-2H3/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-;5-4-,8-7-,11-10-,14-13-,17-16-;4-3-,7-6-,10-9-;.
What are the key properties of [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate?
[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate has a molecular weight of 2601.43 g/mol, XLogP of 35.37, 66 rotatable bonds, 0 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for [2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (5Z,8Z,11Z,14Z,17Z)-henicosa-5,8,11,14,17-pentaenoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl 2-methylpropanoate;[2-oxo-7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-1,3-benzoxazol-3-yl]methyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate is sourced from PubChem (CID 157268121), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).